KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:PHG - US5004723038
29.21 USD
+0.72 (+2.53%)
29.21 USD
0 (0%)
PHG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. PHG has a medium profitability rating, but doesn't score so well on its financial health evaluation. PHG has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- PHG had positive earnings in the past year.
- PHG had a positive operating cash flow in the past year.
- In multiple years PHG reported negative net income over the last 5 years.
- Of the past 5 years PHG 4 years had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of 0.63%, PHG is in the better half of the industry, outperforming 73.66% of the companies in the same industry.
- With a decent Return On Equity value of 1.56%, PHG is doing good in the industry, outperforming 74.73% of the companies in the same industry.
- PHG has a Return On Invested Capital of 4.44%. This is in the better half of the industry: PHG outperforms 75.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| ROIC | 4.44% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 0.93%, PHG is in the better half of the industry, outperforming 73.66% of the companies in the same industry.
- PHG has a better Operating Margin (6.10%) than 71.51% of its industry peers.
- In the last couple of years the Operating Margin of PHG has declined.
- PHG has a worse Gross Margin (43.49%) than 63.98% of its industry peers.
- In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.1% | ||
| PM (TTM) | 0.93% | ||
| GM | 43.49% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHG is destroying value.
- PHG has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, PHG has more shares outstanding
- The debt/assets ratio for PHG is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 1.97 indicates that PHG is not a great score, but indicates only limited risk for bankruptcy at the moment.
- PHG has a Altman-Z score (1.97) which is in line with its industry peers.
- The Debt to FCF ratio of PHG is 14.51, which is on the high side as it means it would take PHG, 14.51 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 14.51, PHG is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
- PHG has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHG is somewhat dependend on debt financing.
- PHG's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PHG is outperformed by 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 14.51 | ||
| Altman-Z | 1.97 |
ROIC/WACC0.66
WACC6.77%
2.3 Liquidity
- PHG has a Current Ratio of 1.32. This is a normal value and indicates that PHG is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.32, PHG is not doing good in the industry: 77.96% of the companies in the same industry are doing better.
- A Quick Ratio of 0.86 indicates that PHG may have some problems paying its short term obligations.
- PHG has a Quick ratio of 0.86. This is amonst the worse of the industry: PHG underperforms 81.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 15.15% over the past year.
- PHG shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
- Looking at the last year, PHG shows a decrease in Revenue. The Revenue has decreased by -1.43% in the last year.
- The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
- PHG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.28% yearly.
- The Revenue is expected to grow by 3.00% on average over the next years.
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y10.28%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 16.79, the valuation of PHG can be described as correct.
- Based on the Price/Earnings ratio, PHG is valued cheaper than 87.10% of the companies in the same industry.
- PHG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.32.
- The Price/Forward Earnings ratio is 16.31, which indicates a correct valuation of PHG.
- 87.10% of the companies in the same industry are more expensive than PHG, based on the Price/Forward Earnings ratio.
- PHG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.30, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.79 | ||
| Fwd PE | 16.31 |
4.2 Price Multiples
- 85.48% of the companies in the same industry are more expensive than PHG, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, PHG is valued a bit cheaper than 75.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.49 | ||
| EV/EBITDA | 12.84 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PHG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.86
PEG (5Y)N/A
EPS Next 2Y4.98%
EPS Next 3Y7.73%
5. Dividend
5.1 Amount
- PHG has a Yearly Dividend Yield of 3.80%. Purely for dividend investing, there may be better candidates out there.
- PHG's Dividend Yield is rather good when compared to the industry average which is at 0.19. PHG pays more dividend than 98.92% of the companies in the same industry.
- PHG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.8% |
5.2 History
- The dividend of PHG decreases each year by -70.49%.
- PHG has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-70.49%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- PHG pays out 199.39% of its income as dividend. This is not a sustainable payout ratio.
DP199.39%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
29.21
+0.72 (+2.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-17 2026-02-17/amc
Inst Owners44.83%
Inst Owner Change-0.07%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap28.13B
Revenue(TTM)17.78B
Net Income(TTM)165.00M
Analysts72.14
Price Target31.61 (8.22%)
Short Float %0.36%
Short Ratio4.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.8% |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP199.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.57%
Min EPS beat(2)14.1%
Max EPS beat(2)31.04%
EPS beat(4)3
Avg EPS beat(4)13.85%
Min EPS beat(4)-11.97%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-0.89%
EPS beat(12)6
Avg EPS beat(12)18.79%
EPS beat(16)6
Avg EPS beat(16)4.51%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-1.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.43%
Revenue beat(12)2
Avg Revenue beat(12)-1.64%
Revenue beat(16)2
Avg Revenue beat(16)-1.76%
PT rev (1m)-2.54%
PT rev (3m)-0.66%
EPS NQ rev (1m)0.95%
EPS NQ rev (3m)3.65%
EPS NY rev (1m)0.43%
EPS NY rev (3m)3.91%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)-0.4%
Revenue NY rev (3m)-0.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.79 | ||
| Fwd PE | 16.31 | ||
| P/S | 1.35 | ||
| P/FCF | 41.49 | ||
| P/OCF | 19.55 | ||
| P/B | 2.27 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.84 |
EPS(TTM)1.74
EY5.96%
EPS(NY)1.79
Fwd EY6.13%
FCF(TTM)0.7
FCFY2.41%
OCF(TTM)1.49
OCFY5.12%
SpS21.66
BVpS12.85
TBVpS-1.67
PEG (NY)3.86
PEG (5Y)N/A
Graham Number22.43
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| ROCE | 5.61% | ||
| ROIC | 4.44% | ||
| ROICexc | 4.44% | ||
| ROICexgc | 11.59% | ||
| OM | 6.1% | ||
| PM (TTM) | 0.93% | ||
| GM | 43.49% | ||
| FCFM | 3.25% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y10.6%
ROICexgc growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 14.51 | ||
| Debt/EBITDA | 2.93 | ||
| Cap/Depr | 46.69% | ||
| Cap/Sales | 3.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 49.6% | ||
| Profit Quality | 350.3% | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 1.97 |
F-ScoreN/A
WACC6.77%
ROIC/WACC0.66
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
EPS Next Y4.35%
EPS Next 2Y4.98%
EPS Next 3Y7.73%
EPS Next 5Y10.28%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
EBIT growth 1Y712.43%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.95%
EBIT Next 3Y19.49%
EBIT Next 5Y15.13%
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%
KONINKLIJKE PHILIPS NVR- NY / PHG FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
ChartMill assigns a fundamental rating of 4 / 10 to PHG.
Can you provide the valuation status for KONINKLIJKE PHILIPS NVR- NY?
ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.
How profitable is KONINKLIJKE PHILIPS NVR- NY (PHG) stock?
KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 4 / 10.
How financially healthy is KONINKLIJKE PHILIPS NVR- NY?
The financial health rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 3 / 10.
Is the dividend of KONINKLIJKE PHILIPS NVR- NY sustainable?
The dividend rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 4 / 10 and the dividend payout ratio is 199.39%.